Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 31, 2006
- Revision received June 5, 2006
- Accepted June 8, 2006
- Published online September 1, 2006.
Copyright & Usage
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- CONSTANTINE S. MITSIADES1,2,
- JOHN BOGDANOS1,3,
- DIMITRIOS KARAMANOLAKIS1,3,
- CONSTANTINE MILATHIANAKIS1,3,
- THEODOROS DIMOPOULOS4 and
- MICHAEL KOUTSILIERIS1
- 1Department of Experimental Physiology, Medical School, University of Athens, Goudi-Athens, Attiki 115 27, Greece
- 2Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston MA 02115, U.S.A.
- 3Urology Clinic, “METAXA” Anticancer Hospital, Piraeus
- 4Urology Clinic, “PANAGIA” General Hospital, Thessaloniki, Greece
- Correspondence to: Michael Koutsilieris, MD, Ph.D., Department of Experimental Physiology, Medical School, University of Athens, 75 Micras Asias St., Goudi-Athens, 115 27 Greece. Tel: +30-210-7462597, Fax: +30-210-7775295, e-mail: mkouts{at}medscape.com
Statistics from Altmetric.com
Cited By...
Jump to section
Related Articles
Cited By...
- Zoledronic Acid Improves Clinical Outcomes in Patients with Bone Metastatic Hormone-naive Prostate Cancer in a Multicenter Clinical Trial
- Dexamethasone plus Somatostatin-analog Manipulation as Bone Metastasis Microenvironment-targeting Therapy for the Treatment of Castration-resistant Prostate Cancer: A Meta-analysis of Uncontrolled Studies
- Dexamethasone plus Octreotide Regimen Increases Anticancer Effects of Docetaxel on TRAMP-C1 Prostate Cancer Model
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials